Product volume - 140 ml Ingredients: Water, Triethylhexanoin, Hydrogenated Poly(C6-14 Olefin), Butylene Glycol, Niacinamide, Methylpropanediol, 1,2-Hexanediol, Phenyl Trimethicone, Diethoxyethyl Succinate, Polyglyceryl-10 Myristate, Borago Officinalis Extract, Centaurea Cyanus Flower Extract, Chamomilla Recutita (Matricaria) Flower/Leaf Extract, Lavandula Angustifolia (Lavender) Flower Water, Hyacinthus Orientalis (Hyacinth) Extract, Salvia Sclarea (Clary) Extract, Ethylhexylglycerin, Hibiscus Esculentus Fruit Extract, Corchorus Olitorius Leaf Extract, Carum Petroselinum (Parsley) Extract, Hexyl Cinnamal, Limonene, Linalool, Fragrance, Hippophae Rhamnoides Oil, Allantoin, Hydrogenated Lecithin, Sodium Gluconate, Glutathione, Adenosine, Cellulose Gum, Melia Azadirachta Leaf Extract, Melia Azadirachta Flower Extract, Curcuma Longa (Turmeric) Root Extract, Ocimum Sanctum Leaf Extract, Corallina Officinalis Extract, Biotin, Biotinoyl Tripeptide-1, Acetyl Hexapeptide-8, Tripeptide-1, Tripeptide-3, Myristoyl Pentapeptide-17, Hexapeptide-9, Gluconolactone, Alpha-Arbutin, Thioctic Acid

In December, Novo Nordisk filed for FDA approval of CagriSema, an injectable combination of GLP-1 and amylin analogues
The underlying literatures remain separate and each is preclinical for musculoskeletal endpoints
doi: 10.1152/ajpendo.00113.2017 16 CostaAAiMNunnNCulottaIHunterJBoudjadjaMBet al